One of the main caveats of previous studies has been the use of three independent Malat1 knockout mouse models, which have led to conflicting results likely because they did not properly recapitulate the potential gain-of-function or dominant phenotypes that Malat1 overexpression may have imparted in the context of cancer [74,75]. This evidence concerns the gene MALAT1 and cancer.